OrbiMed Launches $600 Million Healthcare-Focused Fund

Sep 1 2011 | 10:48am ET

New York-based investment management firm OrbiMed Advisors has closed a new $600 million healthcare fund.

The Luxembourg-domiciled Royal Opportunities fund will invest worldwide in healthcare royalty streams and provide structured debt capital to healthcare companies. Investors in the fund include endowments, foundations and financial institutions.

OrbiMed has tapped three partners—Samuel D. Isaly, Sven H. Borho and W. Carter Neild—along with a dedicated team of four to oversee the fund.

“Life sciences companies are typically dependent on equity markets to raise new capital,” said Tadd Wessel, a managing director on the Royalty Opportunities team. “With this fund, OrbiMed can offer a minimally dilutive capital alternative to fund product launches, M&A opportunities, new product research, and general corporate purposes.”

OrbiMed, which focuses exclusively on the healthcare sector, has over $5 billion in assets under management. The firm employs over 50 professionals in offices in New York, San Francisco, Shanghai, Mumbai and Israel.

In Depth

Related-Company Fees: Normal Industry Practice or Conflicted Compensation?

Nov 11 2015 | 4:23pm ET

Regulatory agencies as well as investors are increasingly exploring whether certain...


Ferrari Roars in Wall Street Debut

Oct 21 2015 | 4:28pm ET

Shares of supercar maker Ferrari jumped as much as 15 percent to a high of nearly...

Guest Contributor

Private Debt - What is the Opportunity?

Nov 11 2015 | 3:28pm ET

In this contributed article, Rob Allard, founding partner of Firebreak Capital...


Editor's Note

    Oct 21 2015 | 10:41am ET

    One of the most unique charity benefits in the hedge fund industry, A Leg To Stand On's (ALTSO's) Hedge Fund Rocktoberfest - NYC, raised nearly $500,000 last Thursday thanks to the generous support of major sponsors and nearly 1,400 attendees from the Tri-State finance, business and hedge fund communities. Read more…